Novartis Gene Therapies Revenue, Growth & Competitor Profile

DBA AveXis, Inc.

Company Profile & Annual Report for Novartis Gene Therapies

Access the complete profile.

Novartis Gene Therapies Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	N/AExact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	2275 Half Day Rd Ste 200 Deerfield, IL 60015

Note: Revenues for privately held companies are statistical evaluations.


Novartis Gene Therapies's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Novartis Gene Therapies's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Novartis Gene Therapies is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Novartis Gene Therapies Annual Revenue and Growth Rate

Novartis Gene Therapies	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	Over $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Novartis Gene Therapies's revenues are gauged from an analysis of company filings.

Novartis Gene Therapies's Income Statement (based on Industry Averages)

Novartis Gene Therapies P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Novartis Gene Therapies is developing and marketing. Novartis Gene Therapies doesn't have any recent trademark applications, indicating Novartis Gene Therapies is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ONEGENE PROGRAM Providing information regarding insurance coverage and reimbursement for prescription drugs; financial administration of a patient assistance program for providing prescription drugs at reduced cost	09/20/2019
ONREPLA Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparation in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression	11/06/2017
GENREPLA Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparation in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression	11/06/2017

See all trademarks and details in the Full Report.

Market Share of Novartis Gene Therapies's Largest Competitors

A competitive analysis shows these companies are in the same general field as Novartis Gene Therapies, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Novartis Gene Therapies. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ABBOTT LABORATORIES	Abbott Park, IL	100
ALLERGAN	North Chicago, IL	67
ASTELLAS US	Northbrook, IL	11
FRESENIUS KABI	Lake Zurich, IL	11
HOSPIRA	Lake Forest, IL	10
HORIZON THERAPEUTICS USA	Deerfield, IL	5

Other Companies at 2275 Half Day Rd, Deerfield IL

Company	Headquarters	Revenue ($ MM)
ALPHA USA	Bannockburn, IL	100
TWS TECHNOLOGY	Bannockburn, IL	87
ELEXA CONSUMER PRODUCTS	Bannockburn, IL	17
LAKE COOK REPORTING	Bannockburn, IL	6

Future Competition: Novartis Gene Therapies's Fastest Growing Competitors

These companies are in the same general field as Novartis Gene Therapies and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)